Highlights • Tumor size has a higher predictive ability for prognosis in IOIO therapy compared to IOTKI. • Time-dependent AUC analysis shows tumor size consistently predicts PFS and OS in…
Abstract Objectives Microwave ablation (MWA) has gained attention as a minimally invasive and safe alternative to surgical intervention for patients with small renal masses; however, its cost-effectiveness in Australia remains…
Highlights • Standard transperitoneal procedure is associated with high complication rates. • Indications: elderly, frail, high risk patients. • Second primary in the bladder with solitary functioning kidney. • Complete…
Highlights • Immediate postoperative intravesical chemotherapy is underutilized. • No demonstrated risk of complications exists following its use. • Elective surgery and shorter operative times are associated with higher utilization….
Highlights • Single-port (SP) retroperitoneal robotic partial nephrectomy (RPN) is associated with a significantly longer ischemia time compared to the multiport (MP) approach, despite comparable perioperative and postoperative outcomes. •…
Highlights • No population-based study validated the survival benefit of neoadjuvant chemotherapy recorded in clinical trials in a stage-specific fashion. • The current study represents the only retrospective analysis that…
Highlights • Controversy remains regarding adjuvant therapy (AT) in patients treated with neoadjuvant chemotherapy (NAC) and radical cystectomy (RC) for muscle-invasive bladder cancer. • Determining variables that may affect cancer-specific…
Highlights • In the absence of evidence from randomized controlled trials, Trimodal Therapy (TMT) for muscle-invasive bladder cancer (MIBC) is usually reserved to patients with poor overall health status. •…
Highlights • Stented radical cystectomies had higher major complications ( P = 0.04); • Stentless radical cystectomy was noninferior in UIAS rate; • Stentless radical cystectomy was noninferior in UIAL rate;…
Abstract Prostate cancer is the second most diagnosed cancer and the fifth leading cause of cancer death among men worldwide. In the 1980s, the development and implementation of Prostate-Specific Antigen…
